Abstract
Recombinant adenoviruses have enormous potential as vectors for gene therapy. They have evolved an efficient method of infection and a wide host range but this leads to concerns about the specificity of gene delivery. In order to target an adenovirus type 5-based vector we have investigated an antibody approach. A virus neutralising scFv antibody fragment was isolated from a phage library and a C-terminal fusion protein with epidermal growth factor (EGF) constructed. This fusion protein, or ‘adenobody’, bound both to the fibre protein of the adenovirus and to the EGF receptor (EGFR) on human cells, and was able to direct adenoviral binding to the new receptor. Using this system the efficiency of viral infection was markedly enhanced and was targeted to the EGFR. The adenobody-directed infection correlated with the level of EGF receptor expressed on the cells and could be blocked by competition with pure EGF. Peptide inhibition experiments suggest that infection is mediated directly through attachment to the EGFR and does not require penton–integrin interactions. This work shows that the ‘adenobody’ approach can enhance the efficiency as well as target adenoviral infection and has numerous potential applications for gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Watkins, S., Mesyanzhinov, V., Kurochkina, L. et al. The ‘adenobody’ approach to viral targeting: specific and enhanced adenoviral gene delivery. Gene Ther 4, 1004–1012 (1997). https://doi.org/10.1038/sj.gt.3300511
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300511
Keywords
This article is cited by
-
Unravelling Receptor and RGD Motif Dependence of Retargeted Adenoviral Vectors using Advanced Tumor Model Systems
Scientific Reports (2019)
-
Molecular Imaging of Biological Gene Delivery Vehicles for Targeted Cancer Therapy: Beyond Viral Vectors
Nuclear Medicine and Molecular Imaging (2010)
-
A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein
Gene Therapy (2008)
-
Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy
Virology Journal (2007)
-
Design and construction of targeted AAVP vectors for mammalian cell transduction
Nature Protocols (2007)